4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:原厂直采,平行进口,授权代理(蚂蚁淘为您服务)
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > cell_proliferation > Ontores/手柄区肽(HRP),大鼠/1mg/ONP10023
商品详细Ontores/手柄区肽(HRP),大鼠/1mg/ONP10023
Ontores/手柄区肽(HRP),大鼠/1mg/ONP10023
Ontores/手柄区肽(HRP),大鼠/1mg/ONP10023
商品编号: ONP10023
品牌: ontorespeptide
市场价: ¥900.00
美元价: 450.00
产地: 美国(厂家直采)
公司:
产品分类: 细胞增殖
公司分类: cell_proliferation
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍
BIOLOGICAL INFORMATION
DescriptionA decoy receptor, or sink receptor, is a receptor that binds a ligand, inhibiting it from binding to its normal receptor. For instance, the receptor VEGFR-1 can prevent vascular endothelial growth factor (VEGF) from binding to the VEGFR-2.When a prorenin-binding protein interacts with the “handle” region of the prorenin prosegment, the prorenin molecule undergoes a conformational change to an enzymatically active state (5). This phenomenon is called nonproteolytic activation.
ApplicationMelanocortin
NoteFor research only, not for human use!
CHEMICAL INFORMATION
CAT No.ONP10023
CAS No.N/A
NameHandle region peptide (HRP),rat
Chemical NameHandle-region-peptide-(HRP),rat
Purity≥98%
SynonymsN/A
FormulaN/A
Molecular Weight1184.54
One Letter CodeRILLKKMPSV
Three Letter CodeArg-Ile-Leu-Leu-Lys-Lys-Met-Pro-Ser-Val
SMILESN/A
InChI KeyN/A
SourceSynthetic
FormDry Powder
ColorWhite
SolubilityN/A
SHIPPING & STORAGE
Storage4 degree ℃ for short term (weeks) and -20 degree ℃ for long term.
Stability≥ 2 years
REFERENCES & CITATIONS
1.Inhibition of diabetic nephropathy by a decoy peptide corresponding to the “handle” region for nonproteolytic activation of prorenin
2.Prorenin and Renin-Induced Extracellular Signal-Regulated Kinase 1/2 Activation in Monocytes Is Not Blocked by Aliskiren or the Handle-Region Peptide
3.(Pro)Renin Receptor Peptide Inhibitor “Handle-Region” Peptide Does Not Affect Hypertensive Nephrosclerosis in Goldblatt Rats
DOCUMENTATIONS
  • COA
  • Data sheet
  • MS
  • RP-HPLC
  • MSDS
  • Handling Instruction
PROMOTIONS & EVENTS
品牌介绍
cGMP肽合成服务肽在临床应用中的使用逐年增加。数十种肽已作为药物销售,数百种处于临床开发的不同阶段。肽由于具有分子量小,靶向选择性高,活性高,毒性低,易于渗透和吸收等突出特点而被用作药物。随着市场规模的不断扩大,越来越多的公司选择参与这一市场。凭借其能够进行商业化的良好生产规范(cGMP)制造的能力以及用于小型非GMP定制肽的能力,ONTORES可以满足从研究到商业化的药物肽开发各个阶段的需求。ONTORES是您值得信赖的高度复杂肽源。我们通过不断投资开发可提供最高质量肽段的专有化学产品,努力超越预期。ONTORES提供灵活的批量大小,从小规模到大规模生产,包括合成,纯化和冻干。